Literature DB >> 15695160

Coupling of human nicotinic acetylcholine receptors alpha 7 to calcium channels in GH3 cells.

Dominik Feuerbach1, Kurt Lingenhöhl, Peter Dobbins, Johannes Mosbacher, Nicola Corbett, Joachim Nozulak, Daniel Hoyer.   

Abstract

The neuronal nicotinic acetylcholine receptor alpha7 (nAChR alpha7) may be involved in cognitive deficits in Schizophrenia and Alzheimer's disease. A fast pharmacological characterization of homomeric alpha7 receptors is mostly hampered by their low functional expression levels in heterologous expression systems. In the present study expression of homomeric nAChR alpha7 was achieved in GH3 rat pituitary cells. Alpha7 subunits were heterologously expressed as components of [125I]-labeled alpha-bungarotoxin binding nAChRs (Bmax: 1.2 pmol/mg protein). Function of the expressed alpha7 ion channels was assessed by patch-clamp recording and calcium imaging. While acetylcholine-induced currents desensitized within much less than 1 s, calcium-sensitive fluorescence transients peaked after 5-10 s and returned to background levels within 30 s only. The fluorescence signal was blocked by isradipine and removal of extracellular sodium indicated that in these cells opening of rapidly desensitizing alpha7 nAChR triggers calcium influx via voltage-gated, DHP-sensitive calcium channels. In this cellular system, agonists revealed the following rank order of potency: epibatidine>anatoxin A>AAR17779>ABT-594>DMPP>nicotine>GTS-21>cytisine>ABT-418>acetylcholine>choline>ABT-089. All of the signals were inhibited by the alpha7 antagonists alpha-bungarotoxin (pIC50: 7.4) and methyllycaconitine (pIC50: 7.8). Further, marketed antidepressants showed antagonistic activity with the following rank order of potency: fluoxetine>imipramine>paroxetine>sertraline. These data illustrate that coupling to voltage-gated calcium channels allows a rapid and reliable functional examination of nAChR alpha7.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15695160     DOI: 10.1016/j.neuropharm.2004.10.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  11 in total

1.  Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives.

Authors:  Christopher Armishaw; Anders A Jensen; Thomas Balle; Richard J Clark; Kasper Harpsøe; Christian Skonberg; Tommy Liljefors; Kristian Strømgaard
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

2.  AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation.

Authors:  Dominik Feuerbach; Nicole Pezous; Markus Weiss; Kasra Shakeri-Nejad; Kurt Lingenhoehl; Daniel Hoyer; Konstanze Hurth; Graeme Bilbe; Christopher R Pryce; Kevin McAllister; Frederique Chaperon; Klaus Kucher; Donald Johns; Thomas Blaettler; Cristina Lopez Lopez
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

Review 3.  Merging old and new perspectives on nicotinic acetylcholine receptors.

Authors:  Roger L Papke
Journal:  Biochem Pharmacol       Date:  2014-01-31       Impact factor: 5.858

4.  Calcium signalling mediated through α7 and non-α7 nAChR stimulation is differentially regulated in bovine chromaffin cells to induce catecholamine release.

Authors:  Laura del Barrio; Javier Egea; Rafael León; Alejandro Romero; Ana Ruiz; Mayte Montero; Javier Alvarez; Manuela G López
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

5.  A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists.

Authors:  Christopher J Armishaw; Narender Singh; Jose L Medina-Franco; Richard J Clark; Krystle C M Scott; Richard A Houghten; Anders A Jensen
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

6.  Allosterically Potentiated α7 Nicotinic Acetylcholine Receptors: Reduced Calcium Permeability and Current-Independent Control of Intracellular Calcium.

Authors:  Douglas R Miller; Habibeh Khoshbouei; Sumanta Garai; Lucas N Cantwell; Clare Stokes; Ganesh Thakur; Roger L Papke
Journal:  Mol Pharmacol       Date:  2020-10-05       Impact factor: 4.436

7.  Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.

Authors:  Sarah M Trattnig; Kasper Harpsøe; Sarah B Thygesen; Louise M Rahr; Philip K Ahring; Thomas Balle; Anders A Jensen
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

Review 8.  Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders.

Authors:  Hans O Kalkman; Dominik Feuerbach
Journal:  Cell Mol Life Sci       Date:  2016-03-15       Impact factor: 9.261

9.  Comparative functional expression of nAChR subtypes in rodent DRG neurons.

Authors:  Nathan J Smith; Arik J Hone; Tosifa Memon; Simon Bossi; Thomas E Smith; J Michael McIntosh; Baldomero M Olivera; Russell W Teichert
Journal:  Front Cell Neurosci       Date:  2013-11-28       Impact factor: 5.505

10.  Semisynthetic analogues of toxiferine I and their pharmacological properties at α7 nAChRs, muscle-type nAChRs, and the allosteric binding site of muscarinic M2 receptors.

Authors:  Darius P Zlotos; Christian Tränkle; Ulrike Holzgrabe; Daniela Gündisch; Anders A Jensen
Journal:  J Nat Prod       Date:  2014-09-05       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.